# GPT-5.4 (R1) Review

**Role:** External referee review
**Model:** openai/gpt-5.4
**Paper:** paper.pdf
**Timestamp:** 2026-03-26T15:43:34.114541
**Route:** OpenRouter + LaTeX
**Review mode:** Tri-model (3 independent reviewers)
**Tokens:** 19386 in / 4874 out
**Response SHA256:** 6ae0840c416ba621

---

This paper studies an important and genuinely interesting question: whether enforcement design, holding statutory text fixed, has economically meaningful incidence. The Illinois BIPA/\textit{Rosenbach} setting is appealing on its face, and the paper is commendably transparent about several core threats, especially few-cluster inference and the 2017–2018 pre-trend. The topic is well chosen for a general-interest audience. However, in its current form, the paper is not publication-ready for a top journal or AEJ: Economic Policy. The central empirical claim remains too fragile relative to the strength of the conclusions.

My main concerns are about identification and inference, not prose. The paper has the ingredients of a potentially valuable paper, but it currently reads more like a provocative first-pass reduced-form exercise than a design that cleanly isolates the causal effect of private biometric litigation risk on employment.

## 1. Identification and empirical design

### A. The core identifying assumption is not credible as currently supported
The main specification is a continuous-exposure triple difference at the county \(\times\) sector \(\times\) quarter level (\S\ref{sec:strategy}, equation (1)). The crucial identifying assumption is that, absent \textit{Rosenbach}, higher-exposure sectors in Illinois border counties would have evolved similarly to higher-exposure sectors in neighboring-state border counties, relative to lower-exposure sectors.

The paper itself presents evidence that undermines this assumption:

- The event study shows a positive deviation in 2017Q3–2018Q4 (\S\ref{subsec:threats}, \S\ref{sec:results}).
- A placebo assigning treatment at 2017Q1 yields a significant positive estimate of +6.5% (\S\ref{subsec:threats}, Table \ref{tab:robust}).

This is not a minor nuisance. In a DDD/continuous-treatment design, a significant pre-treatment differential trend along the treatment gradient is a direct challenge to identification. The paper acknowledges this, but then continues to use the baseline estimate as the headline result in the abstract, introduction, conclusion, and discussion. That is not adequately calibrated to the evidence.

The “trimmed-window” specification dropping 2017–2018 is not a full fix. It is an ad hoc sample selection response to a failed design diagnostic. It may be useful as a sensitivity analysis, but it does not restore identification unless the paper can defend why 2017–2018 alone is contaminated and why dropping it does not induce new biases. As written, that defense is not persuasive.

### B. Border-county design is plausible but incompletely exploited
The border approach is sensible and motivated by \citet{dube2010} and \citet{holmes1998}. But the implementation is weaker than it could be.

The paper appears to compare all Illinois border counties to all neighboring-state border counties pooled together, with county-sector and quarter fixed effects. This does not fully exploit the sharpest source of quasi-experimental variation: local cross-border comparisons. A stronger design would include border-pair or commuting-zone-by-time fixed effects, or at least border-segment-by-time fixed effects, to absorb shocks specific to the Chicago-IN, St. Louis MO-IL, Quad Cities IA-IL, etc. labor markets. As currently specified, the model may still load on heterogeneous macro/local shocks across state borders that are not well netted out by quarter FE alone.

This matters because the institutional discussion itself emphasizes that the strongest cross-border integration is concentrated in a few metro segments. If the identifying logic is local labor market comparability, the empirical design should map more closely to that logic.

### C. Exposure measurement raises nontrivial identification concerns
The biometric exposure index is innovative, but the current implementation is problematic (\S\ref{subsec:exposure}):

1. **Post-treatment measurement**: the exposure index uses O*NET version 29.1 from March 2025, well after treatment. The paper notes this concern but dismisses it too quickly. If occupations, tasks, or recorded technology use changed in response to BIPA, litigation salience, AI diffusion, or broader authentication technology changes post-2019, the exposure measure may partly encode post-treatment adaptation.

2. **Construct validity**: the index mixes:
   - product-embedded biometric use,
   - workplace HR/timekeeping use,
   - identity verification/access control,
   - IT intensity.
   
   But BIPA litigation risk is not obviously proportional to this composite. The legal incidence likely depends heavily on specific use cases, consent practices, vendor contracts, and whether collection occurs by the employer, a client, or a downstream platform.

3. **Researcher degrees of freedom**: the paper mentions keyword matching over 301 technology entries and 50 task statements, plus IT intensity, plus preemption discounts. This creates considerable scope for discretionary coding. In a top-journal setting, I would want a much more formal validation exercise, ideally with pre-registered coding rules or external validation against observed BIPA case exposure by industry.

4. **Preemption discount is ad hoc**: the 60% discount for Finance and Healthcare is not empirically grounded. Since the placebo logic leans heavily on “preempted” sectors, the quantitative exposure adjustment should not be arbitrary.

At minimum, the paper needs extensive robustness to alternative exposure constructions: binary exposure, rank-based exposure, leave-out-one-component exposure, no-IT-intensity version, no-preemption-adjustment version, and exposure calibrated on pre-2019 sources only.

### D. Timing and treatment definition need more discipline
The paper treats 2019Q1 as the treatment onset. That is defensible as a first pass. But the institutional discussion also notes possible anticipation from oral arguments in May 2018 and case buildup before \textit{Rosenbach}. If anticipation is serious enough to explain the pre-trend, then treatment timing is uncertain. If timing is uncertain, the interpretation of post-2019 coefficients as a clean treatment effect is weakened.

A more convincing design would:
- show event-time estimates relative to multiple candidate treatment dates,
- distinguish anticipation windows from post-decision windows,
- justify why 2019Q1 is the policy-relevant discontinuity for firm adjustment rather than lawsuit filing, settlement expectations, or media salience.

### E. Alternative explanations are not fully addressed
The paper argues that null effects in Finance/Healthcare and the null simple DiD help rule out generalized anti-business or anti-tech shocks (\S\ref{subsec:threats}, \S\ref{sec:mechanisms}). That is only partial.

Other Illinois-specific developments could still differentially affect the same sectors that score high on the exposure index:
- tech-sector reorganization,
- platform/telecom trends,
- remote work shifts,
- Chicago-area business climate changes,
- state-specific tax/legal/compliance developments affecting information/professional sectors.

The current controls do not convincingly separate biometric-litigation exposure from broader tech/service-sector Illinois shocks, especially given the failed pre-trend test.

## 2. Inference and statistical validity

This is the paper’s most serious weakness.

### A. Conventional clustered SEs are not valid enough to support the headline claims
The paper appropriately recognizes that “with one treated state and five control states, conventional cluster-robust inference is unreliable” (\S\ref{subsec:threats}). Yet the abstract and introduction still foreground \(p<0.001\) results from six state clusters. That is not acceptable. Once the paper concedes few-cluster asymptotics are unreliable, those conventional p-values should be clearly demoted everywhere, including the abstract.

### B. Randomization inference is better, but still does not rescue the design
The paper presents two RI exercises (\S\ref{subsec:threats}, Appendix \S\ref{sec:id_appendix}):

- state permutation \(p=0.167\),
- timing permutation \(p=0.077\).

These results do not support the paper’s current confidence level.

The state-permutation result is especially important: with the natural cluster-level assignment dimension, the estimate is not conventionally significant even at 10%. The timing-permutation result is only marginal and also complicated by the documented pre-trend/anticipation issue. Moreover, timing permutations in a setting with nonstationary post-2019 shocks (including COVID) are not obviously exchangeable in the way required for clean RI interpretation.

If RI is the “primary inferential frame,” then the paper’s claims should be rewritten around the fact that the strongest assignment-based evidence is suggestive, not strong.

### C. The sector-specific regressions are especially underpowered/inappropriately inferred
Table \ref{tab:sectors} reports separate DiD regressions by sector, with standard errors clustered at the state level. That implies inference on sector-by-sector regressions with effectively six clusters and one treated cluster. The resulting p-values (e.g., Information 0.016, Management 0.046, Professional 0.034) are not credible under conventional asymptotics and should not be used as evidence of precise sector-level significance.

These estimates can be descriptively informative, but inferential claims from them are very weak. If retained, they should be supported with randomization/permutation methods at the sector level or presented as exploratory.

### D. Sample sizes and composition need clearer accounting
The sample sizes are mostly coherent, but there are some concerns:

- Summary table observations sum to 19,737, while regressions use 19,726 due to singleton FE dropping (Table \ref{tab:summary}). Fine, but the treatment of singleton dropping should be systematically documented.
- Some sectors have much sparser support (e.g., Management with 1,263 observations and only 38 counties), which matters for both inference and leverage.
- The paper should report the number of state clusters, county clusters, county-sector cells, and treated/control units in each main specification directly in regression tables.

### E. No discussion of serial correlation corrections beyond state clustering
With a panel this long (2015Q1–2024Q4), serial correlation is likely substantial. State-level clustering with six clusters is inadequate. The paper should consider wild cluster bootstrap methods, Conley-type spatial approaches if appropriate, and aggregation to a higher level (e.g., state-border-segment \(\times\) sector \(\times\) time) for sensitivity. None is a perfect fix with one treated state, but the current inferential treatment is not sufficient.

## 3. Robustness and alternative explanations

### A. Useful robustness checks are present, but the most important ones are missing
The paper does provide:
- pre-COVID restriction,
- sector \(\times\) quarter FE,
- leave-one-state-out,
- placebo timing,
- simple DiD,
- RI.

These are helpful. But key robustness checks are absent:

1. **Border-pair / border-segment-specific time effects**  
   This is probably the single highest-value omitted check.

2. **Alternative exposure measures**  
   As noted above, the paper needs a battery of exposure-construction sensitivity analyses.

3. **Weighting / unweighting**  
   Are results driven by small county-sector cells or large labor markets? Show unweighted and employment-weighted versions.

4. **Winsorization / influential observations**  
   Particularly important for thin sectors and COVID years.

5. **Balanced panel / suppression sensitivity**  
   Since QCEW suppression may be endogenous, show results on a balanced county-sector panel and discuss missingness by treatment intensity.

6. **Alternative geographic restrictions**  
   Adjacent-county pairs only, metro-border segments only, excluding Chicago metro, excluding St. Louis metro, distance-to-border gradients.

7. **Alternative timing windows**  
   2018 anticipation models, excluding 2020–2021, and a stacked short-window design around 2019.

### B. Placebo tests are informative but currently underinterpreted
The placebo at 2017Q1 is not just a “caveat.” It is evidence against the identifying assumption. The paper currently treats it as cautionary while preserving a strong causal narrative. That is too lenient.

A meaningful falsification strategy would include:
- additional placebo laws/dates,
- placebo outcomes less likely to respond (if available),
- placebo states with similar industrial composition but no legal event,
- placebo exposure dimensions unrelated to biometrics.

### C. Mechanism claims remain speculative
The paper is admirably clear that mechanisms are not sharply identified. Still, some interpretive sections go beyond what the evidence can support.

- **Relocation**: inferred largely from border vs all-counties attenuation. But that pattern is also consistent with spillovers, compositional differences, or weaker comparability in the broader sample. Direct “mirror image” control-side gains are not shown.
- **Scale compression**: establishment counts are null and establishment size is imprecise (\(p=0.13\), Table \ref{tab:main}). This is suggestive at best.
- **Technology substitution**: entirely unobserved.

These are fine as hypotheses, not findings.

## 4. Contribution and literature positioning

The paper’s core conceptual contribution—separating enforcement design from substantive legal content—is real and potentially important. That said, the literature positioning is somewhat selective.

### A. The paper should engage more directly with recent DiD/event-study methodology
Given the importance of differential pre-trends and assignment-based inference, the paper should cite and discuss modern design-based work more explicitly. Relevant references include:

- Roth, Sant’Anna, Bilinski, and Poe (2023), on pre-trends and DiD credibility.
- Rambachan and Roth (2023), on sensitivity to violations of parallel trends.
- MacKinnon and Webb (2017, 2020), on wild bootstrap / few treated clusters.
- Conley and Taber (2011), on inference with one treated group.
- Ferman and Pinto (2019, 2021), on inference in small numbers of groups.

These are directly relevant because the paper’s design has one treated state, few clusters, and a failed placebo trend.

### B. Legal/regulatory incidence literature could be broadened
Beyond Autor et al. and privacy papers, there are adjacent literatures on:
- regulatory borders and spatial reallocation,
- litigation risk and firm behavior,
- class actions/private enforcement,
- state legal shocks and local labor markets.

The paper would benefit from sharper differentiation from existing work on legal liability and business activity. Right now the “first reduced-form evidence” claim may be too broad.

### C. Policy-domain citations on BIPA and biometric litigation should be expanded
The institutional discussion is interesting, but if the paper leans heavily on claims about lawsuit counts, industry incidence, and settlements, it should anchor those claims in a more systematic legal/industry evidence base, not just a few references.

## 5. Results interpretation and claim calibration

This is another area where the paper needs substantial recalibration.

### A. Headline conclusions overstate certainty
The abstract says “I find that…” and reports an 11.7% employment reduction as the main result, while relegating the key inferential caveat to the end. Given the state-permutation \(p=0.167\), timing-permutation \(p=0.077\), and placebo pre-trend, the evidence does not support such a confident headline.

A more accurate summary would be that the paper finds **suggestive evidence** of negative employment effects concentrated in high-exposure Illinois border industries after \textit{Rosenbach}, but that identification and inference remain limited.

### B. Magnitudes are presented too assertively
The paper often interprets the 11.7% coefficient as economically large and compares it to other literatures (\S\ref{sec:discussion}, \S\ref{sec:mechanisms}). But because:
- the identifying assumption is challenged,
- the estimate is highly border-specific,
- control spillovers may bias it upward,
- exposure scaling is somewhat arbitrary,

the 11.7% should not be treated as a stable causal elasticity.

### C. Border estimate vs all-counties estimate creates ambiguity the paper does not resolve
The baseline border effect is -11.7%, but the all-counties effect is -1.9% and insignificant (Table \ref{tab:main}). This is a major substantive fact. It means the paper cannot distinguish well between:
1. local cross-border reallocation with limited statewide net job loss,
2. local spillover-induced exaggeration of border contrasts,
3. true destruction concentrated at border-exposed margins.

That ambiguity has first-order implications for policy interpretation. Yet several parts of the discussion and conclusion still speak broadly about employment consequences of enforcement design, rather than more narrowly about border labor market reallocation under one specific regime.

### D. Welfare discussion is too speculative for the current evidence
The “litigation tax” framing is useful conceptually, but some welfare-oriented language—especially around over-deterrence and damages far exceeding social harms—goes beyond what the empirical design identifies. The paper does not measure compliance, privacy benefits, unlawful collection prevalence, or deterrence benefits. It should not imply welfare conclusions absent stronger evidence.

## 6. Actionable revision requests

### 1. Must-fix issues before acceptance

#### 1. Rebuild the inferential framework around valid few-cluster methods
- **Issue:** Headline inference relies too much on six-cluster conventional SEs; RI results are weak.
- **Why it matters:** A paper cannot pass without valid statistical inference.
- **Concrete fix:** Demote conventional clustered p-values; re-center all inference on assignment-based and few-cluster methods. Add Conley-Taber-style inference, wild cluster bootstrap sensitivity where feasible, and clearly present the design as one treated cluster with limited inferential power.

#### 2. Address the failed pre-trend more rigorously
- **Issue:** The 2017–2018 placebo/pre-trend directly threatens identification.
- **Why it matters:** Without credible parallel trends along the exposure gradient, the causal claim is weak.
- **Concrete fix:** Implement formal sensitivity analysis to trend violations (e.g., Rambachan-Roth style bounds if adaptable here), estimate models with group-specific trends or exposure-specific Illinois trends, and show whether substantive conclusions survive. If not, materially weaken the claim.

#### 3. Strengthen the geographic design
- **Issue:** The border logic is not fully reflected in the econometric specification.
- **Why it matters:** Local comparability is central to the design’s credibility.
- **Concrete fix:** Re-estimate with border-pair or border-segment \(\times\) time fixed effects, and ideally commuting-zone-based comparisons. Show results separately for Chicago-IN, St. Louis MO-IL, and other major border segments.

#### 4. Validate and stress-test the exposure measure
- **Issue:** Post-treatment O*NET construction and ad hoc preemption discounts raise concern.
- **Why it matters:** The treatment intensity variable is the paper’s core source of identifying variation.
- **Concrete fix:** Provide a detailed appendix on coding rules; show alternative exposure constructions; validate exposure against observed BIPA lawsuit incidence by industry if possible; use pre-2019 or time-invariant sources where available.

#### 5. Recalibrate the causal language throughout
- **Issue:** The paper’s certainty exceeds what the design supports.
- **Why it matters:** Publication readiness requires claim-evidence alignment.
- **Concrete fix:** Rewrite abstract, introduction, and conclusion to frame findings as suggestive/reduced-form and localized, unless stronger identification/inference can be established.

### 2. High-value improvements

#### 6. Show direct evidence on control-side gains / mirror-image effects
- **Issue:** Relocation is hypothesized but not directly demonstrated.
- **Why it matters:** This is central to interpreting border attenuation.
- **Concrete fix:** Estimate control-side employment changes by exposure and proximity to Illinois; test whether neighboring-state border counties gained in high-exposure sectors post-2019.

#### 7. Expand robustness around sample composition and suppression
- **Issue:** QCEW suppression and sparse sector cells may matter.
- **Why it matters:** Selection and leverage could distort results.
- **Concrete fix:** Report missingness/suppression by sector-state-time; estimate balanced-panel specifications; exclude thin sectors; show leverage diagnostics.

#### 8. Add weighting and influence analyses
- **Issue:** Unknown whether small cells or large counties drive results.
- **Why it matters:** Interpretation differs if the result is a small-cell artifact.
- **Concrete fix:** Show unweighted, employment-weighted, and county-population-weighted versions; leave-out-major-metro analyses.

#### 9. Clarify treatment timing and anticipation
- **Issue:** May 2018 oral arguments and pre-2019 salience complicate treatment timing.
- **Why it matters:** Mis-timed treatment biases dynamic interpretation.
- **Concrete fix:** Present alternative event studies with anticipation windows beginning in 2018; justify the preferred onset.

### 3. Optional polish

#### 10. Narrow the mechanism and welfare claims
- **Issue:** Some discussion sections overreach relative to evidence.
- **Why it matters:** Cleaner calibration will improve credibility.
- **Concrete fix:** Label relocation/fragmentation/technology substitution as hypotheses unless directly identified; avoid normative language on over-deterrence without welfare evidence.

#### 11. Improve literature engagement on modern policy evaluation methods
- **Issue:** Methodological positioning is somewhat dated relative to the design challenges.
- **Why it matters:** Readers will expect awareness of recent DiD/few-cluster debates.
- **Concrete fix:** Add and engage directly with Roth et al., Rambachan-Roth, Conley-Taber, MacKinnon-Webb, Ferman-Pinto, and related work.

## 7. Overall assessment

### Key strengths
- Important and timely question with broad relevance beyond privacy law.
- Clever institutional setting where enforcement changes while statute text is fixed.
- Transparent acknowledgment of major threats, especially few clusters and pre-trends.
- Border-county idea is sensible and potentially powerful.
- Continuous treatment approach is more informative than a crude exposed/unexposed split.

### Critical weaknesses
- The main identifying assumption is directly challenged by the paper’s own placebo/pre-trend evidence.
- Valid statistical inference is not yet strong enough to support the headline causal claims.
- The exposure index is insufficiently validated and partly post-treatment.
- Border design is not implemented at the most credible local-comparison level.
- Interpretation and policy claims are stronger than warranted by the evidence.

### Publishability after revision
There is a potentially publishable paper here, but it requires substantial redesign and recalibration before it could be seriously considered at a top field or general-interest outlet. The current paper is not close to acceptance. The key question is not whether some negative effect may exist—it may—but whether the present design can credibly identify it with valid inference. At the moment, the answer is no.

DECISION: REJECT AND RESUBMIT